A diagnosis of neurofibromatosis type II and schwannoma predisposition syndrome was initially considered but screening of NF2, INI1, SMARCB1, and LZTR1 on the patient’s blood using NGS did not reveal any detectable germline alteration. Here, SMARCB1 is linked to NF2-related schwannomatosis.